Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-1.16M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$326K
-
Number of sells
-
-15
Significant Holders of HCW Biologics Inc. - COM (HCWB) as of Q2 2025
15 filings reported holding HCWB - HCW Biologics Inc. - COM as of Q2 2025.
HCW Biologics Inc. - COM (HCWB) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
.
Largest 10 shareholders include Vanguard Personalized Indexing Management, LLC (0 shares), Pullen Investment Management, LLC (0 shares), AE Wealth Management LLC (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), VANGUARD GROUP INC (0 shares), CITIGROUP INC (0 shares), Avantax Planning Partners, Inc. (0 shares), J.W. COLE ADVISORS, INC. (0 shares), BlackRock, Inc. (0 shares), and NORTHERN TRUST CORP (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.